Apollo Biowellness, Inc., Announces Expiration of Letter of Intent, Negotiations Continue

Core Viewpoint - The Letter of Intent (LOI) between Apollo Biowellness, Inc. and Revive Regenerative, Inc. has expired, and the company is pursuing new partnership opportunities while addressing legal issues related to a former board member [1][3][6]. Group 1: Letter of Intent and Partnership - The LOI, which proposed a closing date of October 31, 2025, is now null and void as no extension was provided by either party [3]. - Ongoing negotiations are taking place for a newly restructured partnership between Apollo Biowellness and Revive Regenerative [3][6]. - The company is actively seeking other business opportunities in addition to the partnership with Revive Regenerative [3][6]. Group 2: Legal Issues - The company is aware of legal issues concerning Jay Lucas, a former board member who was removed in March 2025 for business reasons [4]. - Lucas Brand Equity, which had a minimal capital-raising contract with the company, is not affiliated with LB Equity Advisors Inc. [5]. - The company is investigating past relationships with Mr. Lucas to ensure compliance with legal standards [5]. Group 3: Company Overview - Apollo Biowellness, Inc. and its subsidiary, Evolutionary Biologics, Inc., focus on the discovery, development, and marketing of products aimed at improving human health [7]. - The company aims to position itself as a leader in Regenerative Medicine, utilizing biologic-based products [7]. - Current product development includes natural stem cell mobilizing agents and a dual-acting diet aid [8].